Addyi was initial authorized through the FDA in August 2015 to deal with hypoactive sexual motivation ailment (HSDD) in premenopausal women. That's just another way of claiming it boosts sexual intercourse travel (also known as libido) in Women of all ages who have not reached menopause. It was the very first this sort of drug accepted for this use